Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028
Triton’s
research on the European DNA sequencing market shows that it will develop with
a CAGR of 17.41% in terms of revenue during the forecast years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered in this market are:
• The United Kingdom
• Russia
• France
• Germany
• Spain
• Italy
• Rest of Europe countries
With
the growing prevalence of diseases, Germany has invested significantly in the
field of healthcare and medical research. This is expected to drive the growth
of the German market. According to the OECD, the country spent nearly 3.1% of
its GDP on research and development activities. These investments have fostered
the growth of the nation’s healthcare sector exponentially.
Biotechnology
and pharmaceutical companies in the country are making huge investments in the
area of personalized medicine, which is largely reliant on technologies such as
next-generation sequencing. It is expected that advanced technologies will be
available in hospitals and healthcare facilities in the course of the next few
years. In March 2018, it was reported that the German Research Foundation (DFG)
funded four new sequencing centers in the country, with a total funding of $
17.3 million. These factors are expected to propel the growth of the German
market.
On
the other hand, the market in France is also witnessing increased growth,
thanks to the rising expenditure on healthcare and a rise in the prevalence of
diseases. The expenditure on R&D activities is also expected to grow substantially
over the forecasting phase, which may further fuel the studied market. According
to the OECD, the total R&D spending by the country in 2018 amounted to 2.1%
of the national gross domestic product. Besides, the rise in government
initiatives has also augmented the development of the French market. For
instance, in 2015, the government commissioned the French Plan for Genomic
Medicine 2025, with an investment of about EUR 650 million over the first five
years.
F
Hoffmann-La Roche Ltd (Roche) is a healthcare company engaged in the
development and commercialization of innovative diagnostic and therapeutic
products. It manufactures pharmaceutical products in various therapeutic areas,
such as immunology, oncology, ophthalmology, neuroscience, and infectious
diseases. The company also offers clinical chemistry, immunoassays, laboratory
automation & IT solutions, hematology & hemostasis products, patient
urinalysis products, and self-testing products. Roche provides its products and
services to commercial hospitals, diagnostic laboratories, researchers,
pharmacists, and healthcare professionals. It is headquartered in Basel,
Switzerland.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
DNA SEQUENCING MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE DNA SEQUENCING MARKET
2.2. KEY
INSIGHTS
2.2.1. APPLICATIONS
OF LIQUID BIOPSY
2.2.2. DEVELOPMENT
IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY
2.2.3. NEXT
GENERATION SEQUENCING
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. INDUSTRY
COMPONENTS
2.5. KEY
IMPACT ANALYSIS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CANCER CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.9.3. APPLICATIONS
OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION
2.10. MARKET
RESTRAINTS
2.10.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS
2.10.2. LIMITATIONS
OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING
2.11. MARKET
OPPORTUNITIES
2.11.1. EXTENSIVE
RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
2.11.2. GROWTH
IN GENOME MAPPING PROGRAMS
3. EUROPE
DNA SEQUENCING MARKET – BY PRODUCT
3.1. INSTRUMENTS
& CONSUMABLES
3.1.1. INSTRUMENTS
& CONSUMABLES TYPE
3.1.1.1. CONSUMABLES
3.1.1.2. INSTRUMENTS
3.1.2. INSTRUMENTS
& CONSUMABLES PLATFORM
3.1.2.1. NGS
(NEXT GENERATION SEQUENCING)
3.1.2.1.1. RNA
SEQUENCING
3.1.2.1.2. TARGETED
RESEQUENCING
3.1.2.1.3. WHOLE-EXOME
SEQUENCING
3.1.2.1.4. WHOLE-GENOME
SEQUENCING
3.1.2.1.5. CHIP
SEQUENCING
3.1.2.1.6. DE
NOVO SEQUENCING
3.1.2.1.7. METHYL
SEQUENCING
3.1.2.2. SANGER
3.2. SEQUENCING
SERVICES
3.3. BIOINFORMATICS
4. EUROPE
DNA SEQUENCING MARKET – BY TECHNOLOGY
4.1. SEQUENCING
BY SYNTHESIS
4.2. ION
SEMICONDUCTOR SEQUENCING
4.3. CHAIN
TERMINATION SEQUENCING
4.4. PYROSEQUENCING
4.5. SEQUENCING
BY LIGATION (SBL)
4.6. SINGLE-MOLECULE
REAL-TIME SEQUENCING (SMRT)
4.7. NANOPORE
SEQUENCING
4.8. OTHER
TECHNOLOGIES
5. EUROPE
DNA SEQUENCING MARKET – BY APPLICATION
5.1. BIOMARKER
DISCOVERY
5.2. DIAGNOSTICS
5.3. REPRODUCTIVE
HEALTH
5.4. PERSONALIZED
MEDICINE
5.5. DRUG
DISCOVERY
5.6. AGRICULTURE
& ANIMAL RESEARCH
5.7. FORENSICS
5.8. OTHER
APPLICATIONS
6. EUROPE
DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
6.2. PHARMACEUTICAL
6.3. BIOTECHNOLOGY
COMPANIES
6.4. HOSPITALS
& CLINICS
6.5. OTHER
INDUSTRY VERTICALS
7. EUROPE
DNA SEQUENCING MARKET – COUNTRY OUTLOOK
7.1. GERMANY
7.2. FRANCE
7.3. THE
UNITED KINGDOM
7.4. ITALY
7.5. RUSSIA
7.6. SPAIN
7.7. REST
OF EUROPE
8. COMPETITIVE
LANDSCAPE
8.1. ADAPTIVE
BIOTECHNOLOGIES INC
8.2. AGILENT
TECHNOLOGIES INC
8.3. ASURAGEN
INC
8.4. BGI
GENOMICS
8.5. BIO-RAD
LABORATORIES INC
8.6. DANAHER
CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
8.7. EUROFINS
SCIENTIFIC
8.8. F
HOFFMANN-LA ROCHE
8.9. ILLUMINA
INC
8.10. MERCK
KGAA
8.11. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.12. PERKINELMER
INC
8.13. SIEMENS
HEALTHINEERS AG
8.14. SPIRAL
GENETICS INC
8.15. THERMO
FISHER SCIENTIFIC INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE DNA SEQUENCING MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS &
DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
TABLE 7: EUROPE DNA SEQUENCING MARKET, BY PRODUCT,
2021-2028 (IN $ MILLION)
TABLE 8: EUROPE INSTRUMENTS & CONSUMABLES
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE INSTRUMENTS & CONSUMABLES
MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE NGS MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 11: EUROPE DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: EUROPE DNA SEQUENCING MARKET, BY INDUSTRY
VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE DNA SEQUENCING MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 2: LIMITATIONS OF DNA
SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3: EUROPE DNA SEQUENCING
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 4: EUROPE DNA SEQUENCING
MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE INSTRUMENTS
& CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE INSTRUMENTS
& CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE INSTRUMENTS
& CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE NGS MARKET, BY
RNA SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE NGS MARKET, BY
TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE NGS MARKET, BY
WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE NGS MARKET, BY
WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE NGS MARKET, BY
CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE NGS MARKET, BY DE
NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE NGS MARKET, BY
METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE INSTRUMENTS &
CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE DNA SEQUENCING
MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE DNA SEQUENCING
MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE DNA SEQUENCING
MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 19: EUROPE DNA SEQUENCING
MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE DNA SEQUENCING
MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE DNA SEQUENCING MARKET,
BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 22: EUROPE DNA SEQUENCING
MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE DNA SEQUENCING
MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE DNA SEQUENCING
MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $
MILLION)
FIGURE 25: EUROPE DNA SEQUENCING
MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 26: EUROPE DNA SEQUENCING
MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 27: EUROPE DNA SEQUENCING
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 28: EUROPE DNA SEQUENCING
MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 29: EUROPE DNA SEQUENCING
MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 30: EUROPE DNA SEQUENCING
MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 31: EUROPE DNA SEQUENCING
MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32: EUROPE DNA SEQUENCING
MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 33: EUROPE DNA SEQUENCING
MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 34: EUROPE DNA SEQUENCING
MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 35: EUROPE DNA SEQUENCING
MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 36: EUROPE DNA SEQUENCING
MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 37: EUROPE DNA SEQUENCING
MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028
(IN $ MILLION)
FIGURE 38: EUROPE DNA SEQUENCING
MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
FIGURE 39: EUROPE DNA SEQUENCING
MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 40: EUROPE DNA SEQUENCING
MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 41: EUROPE DNA SEQUENCING
MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 42: GERMANY DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 43: FRANCE DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 44: THE UNITED KINGDOM DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: ITALY DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 46: RUSSIA DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 47: SPAIN DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 48: REST OF EUROPE DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)